SeaStar Medical
48 hedge funds and large institutions have $97M invested in SeaStar Medical in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
2% more funds holding
Funds holding: 47 → 48 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $97.9M → $97M (-$877K)
1.83% less ownership
Funds ownership: 92.28% → 90.45% (-1.8%)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$2.06M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$1.55M |
| 3 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$552K |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$10.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$3.56M |
| 2 |
Goldman Sachs
New York
|
-$2.06M |
| 3 |
Millennium Management
New York
|
-$194K |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$169K |
| 5 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$138K |
ICU Hedge Fund Activity: Q3 2022 in Review
48 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q3 2022, worth a combined $97M — down 0.9% from $97.9M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ICU positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 8 trimmed.
The largest buyer was Yakira Capital Management, opening a new position worth an estimated $2.06M. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $3.56M sold.
- 48 institutional investors held SeaStar Medical (ICU) as of Q3 2022, up from 47 in Q2 2022.
- Funds reported $97M of SeaStar Medical stock for Q3 2022, down 0.9% quarter-over-quarter.
- 2 funds opened new SeaStar Medical positions in Q3 2022 and 1 closed out, a net change of +1 holder.
- The largest SeaStar Medical buyer in Q3 2022 was Yakira Capital Management, an estimated $2.06M added.
- The largest SeaStar Medical seller in Q3 2022 was Boothbay Fund Management, an estimated $3.56M sold.
Based on aggregated 13F filings for Q3 2022.